Insight Inv LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$848K Sell
14,711
-565
-4% -$32.4K 0.4% 57
2026
Q1
$926K Sell
15,276
-550
-3% -$32.1K 0.51% 58
2025
Q4
$854K Sell
15,826
-8,770
-36% -$422K 0.48% 59
2025
Q3
$1.11M Sell
24,596
-6,431
-21% -$300K 0.65% 53
2025
Q2
$1.44M Sell
31,027
-770
-2% -$37.8K 0.96% 44
2025
Q1
$1.94M Buy
31,797
+938
+3% +$54.7K 1.33% 32
2024
Q4
$1.75M Buy
30,859
+8,663
+39% +$484K 1.22% 39
2024
Q3
$1.15M Sell
22,196
-475
-2% -$22.3K 0.96% 48
2024
Q2
$942K Sell
22,671
-2,100
-8% -$94K 0.81% 49
2024
Q1
$1.34M Buy
24,771
+2,530
+11% +$129K 1.17% 44
2023
Q4
$1.14M Sell
22,241
-555
-2% -$29.1K 1.12% 44
2023
Q3
$1.29M Sell
22,796
-535
-2% -$32.8K 1.43% 33
2023
Q2
$1.49M Buy
23,331
+275
+1% +$18.4K 1.54% 32
2023
Q1
$1.6M Sell
23,056
-4,130
-15% -$291K 1.72% 22
2022
Q4
$1.96M Sell
27,186
-195
-0.7% -$14.7K 1.97% 13
2022
Q3
$1.95M Sell
27,381
-760
-3% -$55.1K 2.16% 8
2022
Q2
$2.17M Sell
28,141
-525
-2% -$40K 2.19% 5
2022
Q1
$2.09M Buy
28,666
+2,950
+11% +$198K 1.9% 12
2021
Q4
$1.6M Buy
+25,716
New +$1.51M 1.47% 25

Other funds holding BMY

Insight Inv LLC's BMY Position: Q2 2026 in Review

Insight Inv LLC reduced its Bristol-Myers Squibb (BMY) stake by 3.7% in Q2 2026, selling an estimated $32.4K and leaving 14,711 shares worth $848K. The position accounts for 0.4% of the portfolio, ranked #57.

Insight Inv LLC first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.17M in Q2 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Insight Inv LLC held 14,711 shares of Bristol-Myers Squibb worth $848K as of Q2 2026.
  • Insight Inv LLC sold 565 Bristol-Myers Squibb shares in Q2 2026, an estimated $32.4K.
  • Bristol-Myers Squibb made up 0.4% of Insight Inv LLC's portfolio in Q2 2026, its #57 holding.
  • Insight Inv LLC first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
  • Insight Inv LLC's Bristol-Myers Squibb position peaked at $2.17M in Q2 2022.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Insight Inv LLC's 13F filing for Q2 2026, filed 24 Jul 2026.